ZAI LAB's stock price soared 5.02% during the intraday trading session on Tuesday, marking a significant upward movement for the innovative drug concept stock.
The surge in Hong Kong appears to follow strong performance in U.S. markets, where Zai Lab's American Depositary Receipts (ADRs) surged 9.7% in Monday's trading session. This positive momentum from the U.S. market likely carried over to the Hong Kong listing at the market open.
The broader Hong Kong market also opened higher, with the Hang Seng Index gaining 0.34% and the Hang Seng Tech Index rising 0.45% at the start of trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments